269 related articles for article (PubMed ID: 36155794)
21. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
Jojo GM; Kuppusamy G; De A; Karri VVSNR
Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
[TBL] [Abstract][Full Text] [Related]
22. Formulation of Lipid-Based Nanocarriers of Lacidipine for Improvement of Oral Delivery: Box-Behnken Design Optimization,
Kataria D; Zafar A; Ali J; Khatoon K; Khan S; Imam SS; Yasir M; Ali A
Assay Drug Dev Technol; 2022 Jan; 20(1):5-21. PubMed ID: 34978917
[TBL] [Abstract][Full Text] [Related]
23. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides.
Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y
Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758
[TBL] [Abstract][Full Text] [Related]
24. Chitosan-coated nanostructured lipid carriers for effective brain delivery of Tanshinone IIA in Parkinson's disease: interplay between nuclear factor-kappa β and cathepsin B.
Hassan DM; El-Kamel AH; Allam EA; Bakr BA; Ashour AA
Drug Deliv Transl Res; 2024 Feb; 14(2):400-417. PubMed ID: 37598133
[TBL] [Abstract][Full Text] [Related]
25. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
Singh A; Neupane YR; Mangla B; Kohli K
J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
[TBL] [Abstract][Full Text] [Related]
26. Physical characterization and bioavailability assessment of 5-fluorouracil-based nanostructured lipid carrier (NLC): In vitro drug release, Hemolysis, and permeability modulation.
Mainuddin ; Kumar A; Ratnesh RK; Singh J; Dumoga S; Sharma N; Jindal A
Med Oncol; 2024 Mar; 41(5):95. PubMed ID: 38526657
[TBL] [Abstract][Full Text] [Related]
27. Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics.
Wavikar P; Pai R; Vavia P
J Pharm Sci; 2017 Dec; 106(12):3613-3622. PubMed ID: 28923321
[TBL] [Abstract][Full Text] [Related]
28. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition.
Rapalli VK; Sharma S; Roy A; Singhvi G
Colloids Surf B Biointerfaces; 2021 Oct; 206():111945. PubMed ID: 34216849
[TBL] [Abstract][Full Text] [Related]
29. Preparation, characterization, and
Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K
Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445
[TBL] [Abstract][Full Text] [Related]
30. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
31. Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route.
Abo El-Enin HA; Elkomy MH; Naguib IA; Ahmed MF; Alsaidan OA; Alsalahat I; Ghoneim MM; Eid HM
Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337079
[TBL] [Abstract][Full Text] [Related]
32. Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.
Ali Z; Din FU; Zahid F; Sohail S; Imran B; Khan S; Malik M; Zeb A; Khan GM
BMC Pharmacol Toxicol; 2022 Nov; 23(1):86. PubMed ID: 36443818
[TBL] [Abstract][Full Text] [Related]
33. Enhanced Brain Delivery
Arya RKK; Vijay J; Bisht D; Rashid M; Alfawaz Altamimi AS; Afzal O; Sethiya NK
Curr Drug Deliv; 2023; 20(5):587-600. PubMed ID: 35598246
[TBL] [Abstract][Full Text] [Related]
34. Quality by design (QbD)-based fabrication of atazanavir-loaded nanostructured lipid carriers for lymph targeting: bioavailability enhancement using chylomicron flow block model and toxicity studies.
Gurumukhi VC; Bari SB
Drug Deliv Transl Res; 2022 May; 12(5):1230-1252. PubMed ID: 34110597
[TBL] [Abstract][Full Text] [Related]
35. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
Abd-Elhakeem E; El-Nabarawi M; Shamma R
Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
[TBL] [Abstract][Full Text] [Related]
36. In-vitro and in-vivo evaluation of chitosan-based thermosensitive gel containing lorazepam NLCs for the treatment of status epilepticus.
Taymouri S; Minaiyan M; Ebrahimi F; Tavakoli N
IET Nanobiotechnol; 2020 Apr; 14(2):148-154. PubMed ID: 32433032
[TBL] [Abstract][Full Text] [Related]
37. Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study.
Pokharkar V; Patil-Gadhe A; Palla P
Biomed Pharmacother; 2017 Oct; 94():150-164. PubMed ID: 28759752
[TBL] [Abstract][Full Text] [Related]
38. Chitosan modified 5-fluorouracil nanostructured lipid carriers for treatment of diabetic retinopathy in rats: A new dimension to an anticancer drug.
Sharma DS; Wadhwa S; Gulati M; Kumar B; Chitranshi N; Gupta VK; Alrouji M; Alhajlah S; AlOmeir O; Vishwas S; Khursheed R; Saini S; Kumar A; Parveen SR; Gupta G; Zacconi F; Chellappan DK; Morris A; Loebenberg R; Dua K; Singh SK
Int J Biol Macromol; 2023 Jan; 224():810-830. PubMed ID: 36302483
[TBL] [Abstract][Full Text] [Related]
39. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1.
Garg NK; Tyagi RK; Singh B; Sharma G; Nirbhavane P; Kushwah V; Jain S; Katare OP
Int J Pharm; 2016 Feb; 499(1-2):301-320. PubMed ID: 26768725
[TBL] [Abstract][Full Text] [Related]
40. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization,
Abdelmonem R; Al-Samadi IEI; El Nashar RM; Jasti BR; El-Nabarawi MA
Drug Deliv; 2022 Dec; 29(1):2868-2882. PubMed ID: 36065090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
